Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $38.05, giving the company a market capitalization of 4.04B. It carries a P/E multiple of 45.85.
During the trading session on 2026-02-06, Corcept Therapeutics(CORT) shares reached a daily high of $40.75 and a low of $38.00. At a current price of $38.05, the stock is +0.1% higher than the low and still -6.6% under the high.
Trading activity shows a volume of 1.06M, compared to an average daily volume of 2.24M.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
CORT News
If you are wondering whether Corcept Therapeutics at around US$38.36 is a bargain or a trap, you are in the right place to unpack what that price really implies...
Shares of Corcept Therapeutics (CORT) were slipping after the FDA updated a Complete Response Letter for the company’s relacorilant capsules, with the FDA sayin...
Investors eyeing a purchase of Corcept Therapeutics Inc (Symbol: CORT) stock, but tentative about paying the going market price of $39.61/share, might benefit f...
